Resmed Inc (RMD) Q2 2020 Earnings Call Transcript thumbnail

Resmed Inc (RMD) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Resmed Inc (NYSE:RMD)Q2 2020 Earnings CallJan 30, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the Second Fiscal Year 2020 ResMed Earnings Conference Call. My name is Christine and I’ll be your operator for today’s call. At this time, all participants are in a listen-only…

Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

Excessive daytime sleepiness is a major symptom in people with obstructive sleep apnea that persists in some patients despite use of continuous positive airway pressureSunosi is the only licensed therapy in Europe for the treatment of excessive daytime sleepiness in adults living with obstructive sleep apneaDUBLIN, Jan. 20, 2020 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ)…